Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
2 other identifiers
interventional
500
1 country
5
Brief Summary
The goal of this research is to follow Barrett's Esophagus participants for 3 years using the tethered capsule endomicroscopy device with distal scanning and a compact imaging system in a multi-site clinical study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2017
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2017
CompletedFirst Submitted
Initial submission to the registry
February 6, 2018
CompletedFirst Posted
Study publicly available on registry
March 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
October 22, 2025
October 1, 2025
10.7 years
February 6, 2018
October 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
We will be measuring the size of the area affected by Barrett's.
4 years
Study Arms (1)
Experimental OFDI capsule imaging
EXPERIMENTALParticipants will swallow the OFDI capsule and imaging will be acquired using the OFDI imaging system. Intervention: 'Tethered Capsule Endomicroscopy (TCE) Imaging of Barrett's esophagus using OFDI capsule
Interventions
Tethered Capsule Endomicroscopy will be used to detect Barrett's Esophagus
Eligibility Criteria
You may qualify if:
- Participants over the age of 18
- Participants who are capable of giving informed consent
- Participants with a diagnosis of BE without high grade dysplasia, intramucosal adenocarcinoma or esophageal adenocarcinoma, confirmed by endoscopic biopsy
- Participants who had or will have a standard of care EGD within 15 months, exceptions to this can be submitted to the coordinating center (MGH) for approval
You may not qualify if:
- Participants with prior endoscopic ablation or resection treatment of BE at enrollment visit
- Participants with esophageal fistula and/or esophageal strictures
- Participants with the inability to swallow capsules
- Concomitant chemotherapy treatment
- Self reported pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- Columbia Universitycollaborator
- Mayo Cliniccollaborator
- Kansas City Veteran Affairs Medical Centercollaborator
- National Institutes of Health (NIH)collaborator
- National Cancer Institute (NCI)collaborator
Study Sites (5)
Mayo Clinic - Jacksonville
Jacksonville, Florida, 32224, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Mayo Clinic - Rochester
Rochester, Minnesota, 55905, United States
VA Medical Center
Kansas City, Missouri, 64128, United States
Columbia University Medical Center
New York, New York, 10032, United States
Related Publications (1)
Dong J, Grant C, Vuong B, Nishioka N, Gao AH, Beatty M, Baldwin G, Baillargeon A, Bablouzian A, Grahmann P, Bhat N, Ryan E, Barrios A, Giddings S, Ford T, Beaulieu-Ouellet E, Hosseiny SH, Lerman I, Trasischker W, Reddy R, Singh K, Gora M, Hyun D, Queneherve L, Wallace M, Wolfsen H, Sharma P, Wang KK, Leggett CL, Poneros J, Abrams JA, Lightdale C, Leeds S, Rosenberg M, Tearney GJ. Feasibility and Safety of Tethered Capsule Endomicroscopy in Patients With Barrett's Esophagus in a Multi-Center Study. Clin Gastroenterol Hepatol. 2022 Apr;20(4):756-765.e3. doi: 10.1016/j.cgh.2021.02.008. Epub 2021 Feb 4.
PMID: 33549871DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillermo Tearney, MD, PhD
MGH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pathology, HMS
Study Record Dates
First Submitted
February 6, 2018
First Posted
March 8, 2018
Study Start
April 4, 2017
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
October 22, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share